NOVONIX Statistics
Total Valuation
NOVONIX has a market cap or net worth of $242.34 million. The enterprise value is $289.86 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
NOVONIX has 636.20 million shares outstanding. The number of shares has increased by 15.96% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 636.20M |
| Shares Change (YoY) | +15.96% |
| Shares Change (QoQ) | +24.40% |
| Owned by Insiders (%) | 3.99% |
| Owned by Institutions (%) | 25.51% |
| Float | 642.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 40.86 |
| Forward PS | n/a |
| PB Ratio | 1.68 |
| P/TBV Ratio | 1.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 48.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.50.
| Current Ratio | 0.93 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.63 |
Financial Efficiency
Return on equity (ROE) is -43.89% and return on invested capital (ROIC) is -14.29%.
| Return on Equity (ROE) | -43.89% |
| Return on Assets (ROA) | -13.27% |
| Return on Invested Capital (ROIC) | -14.29% |
| Return on Capital Employed (ROCE) | -27.91% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.74 |
Taxes
In the past 12 months, NOVONIX has paid $97,687 in taxes.
| Income Tax | 97,687 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.25% in the last 52 weeks. The beta is 0.79, so NOVONIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -38.25% |
| 50-Day Moving Average | 1.54 |
| 200-Day Moving Average | 1.30 |
| Relative Strength Index (RSI) | 42.97 |
| Average Volume (20 Days) | 1,405,577 |
Short Selling Information
| Short Interest | 1.40M |
| Short Previous Month | 902,394 |
| Short % of Shares Out | 0.22% |
| Short % of Float | 0.22% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
In the last 12 months, NOVONIX had revenue of $5.93 million and -$66.25 million in losses. Loss per share was -$0.12.
| Revenue | 5.93M |
| Gross Profit | 4.52M |
| Operating Income | -50.93M |
| Pretax Income | -66.15M |
| Net Income | -66.25M |
| EBITDA | -46.95M |
| EBIT | -50.93M |
| Loss Per Share | -$0.12 |
Full Income Statement Balance Sheet
The company has $24.82 million in cash and $71.80 million in debt, giving a net cash position of -$46.98 million or -$0.07 per share.
| Cash & Cash Equivalents | 24.82M |
| Total Debt | 71.80M |
| Net Cash | -46.98M |
| Net Cash Per Share | -$0.07 |
| Equity (Book Value) | 143.83M |
| Book Value Per Share | 0.23 |
| Working Capital | -3.84M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$40.51 million and capital expenditures -$54.47 million, giving a free cash flow of -$94.98 million.
| Operating Cash Flow | -40.51M |
| Capital Expenditures | -54.47M |
| Free Cash Flow | -94.98M |
| FCF Per Share | -$0.15 |
Full Cash Flow Statement Margins
| Gross Margin | 76.25% |
| Operating Margin | -858.71% |
| Pretax Margin | -1,115.23% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |